Main Menu
Home
News
Contact Us
Search
Latest News
Charity gives support to compensation campaign
Saturday, 02 February 2008


Justice for Asbestos Families Campaign is being backed by the Mick Knighton Mesothelioma Research Fund. It is a campaign which highlights the unfairness in the way compensation for bereavement is awarded to families who have lost a relative to mesothelioma. Mesothelioma is a devastating disease which has no cure, and it is often the case that sufferers die within just months of being diagnosed with the illness.

Read more...
 
Appeal over asbestosis claim
Saturday, 02 February 2008


David Lawrence Robinson, 77, was diagnosed with mesothelioma, the fatal asbestos-related disease, in July 2007.
 Mr Robinson, known as Robbie to his friends, is thought to have been exposed to asbestos dust while working for Thos. & Jas. Harrison Ltd/Charente Ltd from 1948 to 1951 and again from 1964 to 1966.

 

Referred from: http://www.thisiswirral.co.uk/display.var.2000036.0.appeal_over_asbestosis_claim.php

Read more...
 
LegalView Relaunches Traumatic Brain Injury Portal To Include ...
Saturday, 02 February 2008


One such legal issue is mesothelioma cancer. Mesothelioma is caused by the inhalation of asbestos fibers into the lungs. It can take years for mesothelioma to form and affect an individual, by which time the cancer becomes incurable. Mesotehlioma is often misdiagnosed but it is a deadly illness for which a victim should seek help to receive compensation.

Read more...
 
Unite Calls for an End to Bureaucracy as Nice Finally Approves ...
Saturday, 02 February 2008


Alimta, a treatment for the asbestos related disease mesothelioma, was finally approved by NICE yesterday.
 This follows a long fight by Unite and other support groups to ensure sufferers receive this treatment on the NHS.
 The delay caused by a catalogue of appeals, resulted in a very long appraisal process and led to extreme distress for mesothelioma patients who should have benefited from treatment with Alimta a long time ago. The situation was complicated by patients in Scotland, the North West and North East receiving this drug treatment whilst other sufferers in other parts of the UK where refused treatment. 
 

Read more...
 
Minnesotan claims sales rep father suffered mesothelioma
Saturday, 02 February 2008


16, alleging his father died from mesothelioma. Bruno Zagar claims his father, Anthony, was diagnosed with mesothelioma on Jan. 1, 2004, and died on Dec. 2, 2004. He claims that during the course of his father's employment and during home and automotive repairs he was exposed to and inhaled, ingested or otherwise absorbed asbestos fibers emanating from certain products he was working with and around.

Read more...
 
LegalView Informs Readers of A Canadian Treatment Study That Looks ...
Saturday, 02 February 2008


LegalView informs its mesothelioma blog ( http://mesothelioma.legalview.com ) readers of a Canadian treatment study that is attempting to find early detection of asbestos exposure and mesothelioma in victims. According to information available at the mesothelioma blog, the study is being conducted by the University Health Network in Toronto. Volunteers who may have been exposed to asbestos are being asked to receive serial low-doses of computed tomography treatments in order to uncover how mesothelioma develops, according to the blog.

Read more...
 
NICE OKs mesothelioma drug
Saturday, 02 February 2008


Pemetrexed Disodium (Alimta) will now be available across the NHS for malignant pleural mesothelioma in certain cases after NICE threw out an appeal.

Read more...
 
LegalView Blog Notifies Readers of a New Experimental
Saturday, 02 February 2008


Readers of LegalView's mesothelioma blog recently alerted readers of an experimental asbestos removal trial that is being used as an allegedly cheaper and safer method. LegalView provides information on asbestos removal as well as treatments and jury verdicts. 
 

Read more...
 
Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
Saturday, 02 February 2008


In addition to an ongoing Phase IIIb study in malignant mesothelioma, Alfacell is conducting a Phase I/II trial of ONCONASE in non-small cell lung cancer (NSCLC) and other solid tumors.

Read more...
 
Two thirds of Highland primary schools contain asbestos
Saturday, 02 February 2008

Two thirds of Highland primary schools contain asbestos
Mesothelioma can be latent in the body for a period of between 50 and 60 years. They have a higher probability of surviving long enough for the disease to develop."

Read more...
 

Copyright 2005-2008 mesotheliomaattorneyhelp.com. All rights reserved.